Webinar explores hybrid monitoring for IVD clinical studies

TORONTO, September 4, 2026, In an effort to enhance in vitro diagnostic (IVD) clinical study performance, Xtalks is hosting a free webinar on October 1, 2026, at 10 a.m. EDT (4 p.m. CEST / EU-Central). The event will explore how a hybrid monitoring approach can strengthen oversight and improve study execution.

The webinar, featuring experts from ARC Regulatory, will delve into how sponsor delegation, centralized oversight, and on-site monitoring can work together to ensure regulatory compliance, quality, and coordination across various sites and vendors. Attendees will gain insights into how integrated clinical, regulatory, and quality expertise can reduce operational burden and support regulatory submissions.

“Clinical performance studies for IVDs are becoming increasingly complex,” said Dr. Ciara Devlin, Research Operations Lead at ARC Regulatory. “Successfully managing these competing priorities requires a coordinated approach that combines clinical, regulatory, and quality expertise.”

ARC's Sponsor Delegation service, developed by the company’s expert regulatory team, is the first model of its kind in the market. This service enables sponsors to access experienced clinical and regulatory leadership while retaining overall responsibility for their studies. Delegated specialists can provide day-to-day coordination, governance, and oversight, ensuring activities remain aligned with regulatory expectations, study timelines, and quality objectives.

The webinar will also examine the value of combining centralized oversight with balanced on-site monitoring to create a more agile and risk-based monitoring strategy. This hybrid approach provides greater visibility across study activities, supports proactive risk identification, enhances communication between stakeholders, and enables faster decision-making when challenges arise.

“By reducing operational complexity and strengthening governance, sponsors can remain focused on innovation and bringing new diagnostic technologies to market with greater confidence,” said Andrew Mercier, Alliance Manager at ARC Regulatory.

Whether an organization has limited internal resources or is looking to optimize existing study management processes, sponsor delegation offers a flexible, scalable solution tailored to the needs of each study. Attendees will learn how this approach can improve consistency, minimize duplication of effort, and help generate robust clinical evidence that supports successful regulatory submissions.

To register for the webinar and gain further insights into hybrid monitoring, interested professionals can visit the Xtalks website. The event will feature Dr. Ciara Devlin and Andrew Mercier from ARC Regulatory, who will provide practical experience and expert perspectives on the topic.

Xtalks, the leading platform for professionals in the life sciences industry, aims to empower organizations with trusted knowledge and collaborative insights. By hosting this webinar, Xtalks continues to support informed decision-making in a fast-evolving sector.